Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Skin Neoplasms × oblimersen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Solid Tumors 1 Skin Neoplasms 1 Neoplasms 1 Leukemia, Lymphoid 1

Interventions

pembrolizumab 14 Nivolumab 8 cemiplimab 6 Ipilimumab 6 dabrafenib 4 binimetinib 4 Dacarbazine 4 trametinib 3 encorafenib 3 zanolimumab 2 talabostat 2 lifileucel 2 aldesleukin 2 Vemurafenib 2 Tablets 2 Semaxinib 2 Intravital Microscopy 2 Interleukin-2 2 Fluorouracil 2 Drug Therapy 2 Allovectin-7 2 vitespin 1 veliparib 1 varlilumab 1 tozuleristide 1 tin etiopurpurin 1 tilsotolimod 1 spartalizumab 1 sotigalimab 1 sonidegib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00518895 2011-11-07

AGENDA

Genta Incorporated

Phase 3 Completed

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡